Ease My Trip Q2 FY23 – Sector tailwinds versus competitive intensity?

While competition is increasing, the travel & tourism market is also growing, making Ease My Trip a long-term survivor EaseMyTrip (Image source: Shutterstock/File) PRO Only Highlights–  Quarterly performance largely backed by improved realisations–  Medium-term triggers China plus and protectionist measures for tyre industry–  Valuations not inexpensive; but improved medium-term outlook Highlights Strong revenue performance […]

Continue Reading

Energy security, despondency on global warming targets in focus at COP27: ReNew Power head Sumant Sinha

The 27th Conference of the Parties to the United Nations Framework Convention on Climate Change (UNCC), known as COP27, started in Egypt on November 6. It has greater corporate participation this year, signalling the realisation that while governments make the policies, it will be up to the companies to execute the plans, ReNew Power founder […]

Continue Reading

Cummins, Tata Motors team up for hydrogen-powered engines

Several automakers, including Tata Motors, are aggressively shifting towards greener forms of energy for their vehicles as they try to reduce their dependence on fossil fuels, with India targeting net-zero carbon emissions by 2070. Reuters November 15, 2022 / 08:29 AM IST Representative image ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // […]

Continue Reading

Alembic gets USFDA nod for generic cancer treatment medication

The company has received approval from the US Food and Drug Administration (USFDA) to market its product which is a generic version of Hikma Pharmaceuticals USA Inc product, Alembic Pharmaceuticals said in a statement. PTI November 14, 2022 / 11:16 AM IST Pharma ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ […]

Continue Reading

Fleeing China? Credit crises lurk everywhere in emerging markets

Credit crises are lurking in every corner of emerging markets and the latest scares are no less dramatic. (Photographer: Qilai Shen/Bloomberg) Global investors who had enough of Chinese real estate developers’ default drama have been looking for safe havens elsewhere. They are coming away feeling disappointed. Credit crises are lurking in every corner of emerging markets and the […]

Continue Reading

Mercedes-Benz’s EV ramp-up could position India as manufacturing base

The ‘Made in India’ EQS 580 generated 300-plus confirmed bookings within the first two weeks of launch (Image: Mercedes Benz) Setting up a fully integrated business unit for the auto industry in a foreign country takes money, time and, most importantly, market-readiness in terms of adoption and affordability. But how would that work when it’s for a new […]

Continue Reading

Pharma stocks slip on concerns over first anti-competitive US lawsuit against ‘Revlimid’ makers

The suit is expected to impact Natco Pharma, Dr Reddy’s Labs, Cipla, and Zydus Lifesciences. All these companies had launched Revlimid during the second COVID-19 wave in September 2021 The 85-page long complaint alleges that a multifaceted, anti-competitive scheme was initiated by Celgene and BMS and later joined by Natco and Teva. This according to […]

Continue Reading

Muthoot Finance: Why it is a long-term sell

If the gold-loan company tries to recoup growth, it will come at the cost of margin, given the competitive intensity Representative image PRO Only Highlights–  Quarterly performance largely backed by improved realisations–  Medium-term triggers China plus and protectionist measures for tyre industry–  Valuations not inexpensive; but improved medium-term outlook Highlights No improvement seen post […]

Continue Reading